Mediolanum International Funds’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.3M Buy
475,762
+71,529
+18% +$6.38M 0.42% 44
2026
Q1
$28.4M Buy
404,233
+122,456
+43% +$9.43M 0.3% 82
2025
Q4
$22.5M Buy
281,777
+249,723
+779% +$19.7M 0.22% 112
2025
Q3
$2.42M Sell
32,054
-152,661
-83% -$10.5M 0.03% 323
2025
Q2
$12.7M Buy
184,715
+158,726
+611% +$10.4M 0.15% 158
2025
Q1
$1.74M Buy
25,989
+2,878
+12% +$172K 0.02% 334
2024
Q4
$1.01M Buy
23,111
+9,917
+75% +$556K 0.01% 376
2024
Q3
$809K Sell
13,194
-4,024
-23% -$235K 0.01% 392
2024
Q2
$938K Sell
17,218
-6,471
-27% -$405K 0.02% 352
2024
Q1
$1.88M Buy
+23,689
New +$1.81M 0.03% 304

Other funds holding CVS

Mediolanum International Funds's CVS Position: Q2 2026 in Review

Mediolanum International Funds increased its CVS Health (CVS) stake by 18% in Q2 2026, buying an estimated $6.38M and bringing the position to 475,762 shares worth $49.3M. The position accounts for 0.42% of the portfolio, ranked #44.

Mediolanum International Funds first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Mediolanum International Funds held 475,762 shares of CVS Health worth $49.3M as of Q2 2026.
  • Mediolanum International Funds bought 71,529 CVS Health shares in Q2 2026, an estimated $6.38M.
  • CVS Health made up 0.42% of Mediolanum International Funds's portfolio in Q2 2026, its #44 holding.
  • Mediolanum International Funds first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.